×
0.0103761348897536 0.0265758754863814 0.00778210116731524 0.0168612191958496 -0.020752269779507 0.040207522697795 0.0499351491569391 0.0959792477302206
Stockreport

Abeona down 17% on delay of late-stage study of EB-101 in RDEB [Seeking Alpha]

Abeona Therapeutics, Inc (ABEO)  More Company Research Source: Seeking Alpha
Last abeona therapeutics, inc earnings: 11/14 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.abeonatherapeutics.com
PDF Abeona Therapeutics ( ABEO ) is down on 70% higher volume in apparent response to an extended timeline for the start of a Phase 3 clinical trial evaluating autologous cell therapy EB-101 in patients with recessive dystrophic epidermolysis bullosa (RDEB), the most severe type of EB. Management had said that the study would launch in the second half of this year but now expects it to start in 2019 while CMC work and comparability studies are completed. See all stocks on the move » Now read: Oncolytics Biotech (ONCY) Investor Presentation - Slideshow » Subscribe for full text news in your inbox [Read more]

IMPACT SNAPSHOT EVENT TIME: ABEO
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ABEO alerts

from News Quantified
Opt-in for
ABEO alerts

from News Quantified